Loading...
Results from several studies have suggested that the antiseizure drug topiramate (Topamax) is associated with adverse cognitive effects. In this double-blind randomized trial, researchers compared the cognitive effects of topiramate and another antiseizure drug, gabapentin (Neurontin and generics). The study was supported by the manufacturer of gabapentin.
Forty healthy adult volunteers (mean age, 31) received 12-week courses of topiramate (titrated to 400 mg daily), gabapentin (titrated to 3600 mg daily), or placebo; cognitive tests were performed at baseline and 12 weeks. Topiramate recipients performed significantly more poorly than gabapentin recipients on 4 of 6 "target" tests and on 12 of 24 tests overall. In contrast, gabapentin recip…